title: Fibroblastic reticular cells of the lymph node are required for retention of resting but not activated CD8+ T cells.
abstract: Fibroblastic reticular cells (FRCs), through their expression of CC chemokine ligand (CCL)19 and CCL21, attract and retain T cells in lymph nodes (LNs), but whether this function applies to both resting and activated T cells has not been examined. Here we describe a model for conditionally depleting FRCs from LNs based on their expression of the diphtheria toxin receptor (DTR) directed by the gene encoding fibroblast activation protein-α (FAP). As expected, depleting FAP(+) FRCs causes the loss of naïve T cells, B cells, and dendritic cells from LNs, and this loss decreases the magnitude of the B- and T-cell responses to a subsequent infection with influenza A virus. In contrast, depleting FAP(+) FRCs during an ongoing influenza infection does not diminish the number or continued response of activated T and B cells in the draining LNs, despite still resulting in the loss of naïve T cells. Therefore, different rules govern the LN trafficking of resting and activated T cells; once a T cell is engaged in antigen-specific clonal expansion, its retention no longer depends on FRCs or their chemokines, CCL19 and CCL21. Our findings suggest that activated T cells remain in the LN because they down-regulate the expression of the sphingosine-1 phosphate receptor-1, which mediates the exit of lymphocytes from secondary lymphoid organs. Therefore, LN retention of naïve lymphocytes and the initiation of an immune response depend on FRCs, but is an FRC independent and possibly cell-autonomous response of activated T cells, which allows the magnitude of clonal expansion to determine LN egress.
authors.affiliation: Department of Medicine and Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom; and dtf1000@cam.ac.uk ad596@cam.ac.uk.
authors.forename: Alice E
authors.initials: AE
authors.lastname: Denton
authors.affiliation: Department of Medicine and Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom; and.
authors.forename: Edward W
authors.initials: EW
authors.lastname: Roberts
authors.affiliation: Lymphocyte Signalling and Development, Babraham Institute, Cambridge CB22 3AT, United Kingdom.
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Linterman
authors.affiliation: Department of Medicine and Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom; and dtf1000@cam.ac.uk ad596@cam.ac.uk.
authors.forename: Douglas T
authors.initials: DT
authors.lastname: Fearon
mesh_terms: D000818:Animals; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology* / Q000276:immunology; D022202:Chromosomes, Artificial, Bacterial; D005260:Female; D005347:Fibroblasts / Q000166:cytology; D006706:Homeostasis; D008198:Lymph Nodes / Q000166:cytology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic
keywords: T-cell migration; lymph node stroma; viral infection
references.citation: Immunity. 1998 Jun;8(6):683-91
references.pmid: 9655482
references.citation: J Immunol. 2011 Dec 1;187(11):5733-44
references.pmid: 22039305
references.citation: Cell. 1999 Oct 1;99(1):23-33
references.pmid: 10520991
references.citation: Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18036-41
references.pmid: 23071319
references.citation: J Exp Med. 2010 Jan 18;207(1):17-27
references.pmid: 20026661
references.citation: J Exp Med. 1999 Feb 1;189(3):451-60
references.pmid: 9927507
references.citation: Nature. 2004 Jan 22;427(6972):355-60
references.pmid: 14737169
references.citation: Nat Immunol. 2003 Apr;4(4):361-5
references.pmid: 12640451
references.citation: J Exp Med. 2013 Jun 3;210(6):1137-51
references.pmid: 23712428
references.citation: Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20212-7
references.pmid: 24277834
references.citation: J Exp Med. 2013 Jun 3;210(6):1125-35
references.pmid: 23712432
references.citation: Nature. 2009 Mar 12;458(7235):211-4
references.pmid: 19182777
references.citation: Cancer Immunol Res. 2014 Feb;2(2):121-6
references.pmid: 24778275
references.citation: Proc Natl Acad Sci U S A. 1990 Sep;87(18):7235-9
references.pmid: 2402505
references.citation: PLoS One. 2011;6(11):e27618
references.pmid: 22110693
references.citation: Immunity. 2008 Jan;28(1):122-33
references.pmid: 18164221
references.citation: Arthritis Res Ther. 2006;8(6):R171
references.pmid: 17105646
references.citation: J Immunol. 2009 Nov 15;183(10):6395-402
references.pmid: 19841174
references.citation: Immunity. 2006 Dec;25(6):989-1001
references.pmid: 17112751
references.citation: Nat Immunol. 2007 Nov;8(11):1255-65
references.pmid: 17893676
references.citation: J Exp Med. 2002 Oct 7;196(7):957-68
references.pmid: 12370257
references.citation: Immunity. 2013 Apr 18;38(4):782-91
references.pmid: 23601687
references.citation: Immunity. 2013 May 23;38(5):1013-24
references.pmid: 23623380
references.citation: Eur Heart J. 2011 Nov;32(21):2713-22
references.pmid: 21292680
references.citation: Mol Cell Biol. 2000 Feb;20(3):1089-94
references.pmid: 10629066
references.citation: Science. 2010 Nov 5;330(6005):827-30
references.pmid: 21051638
references.citation: Nat Immunol. 2012 Apr 01;13(5):499-510
references.pmid: 22466668
references.citation: Nat Immunol. 2009 Apr;10(4):394-402
references.pmid: 19252492
references.citation: PLoS One. 2011;6(11):e26138
references.pmid: 22110583
references.citation: Hepatology. 1999 Jun;29(6):1768-78
references.pmid: 10347120
references.citation: J Exp Med. 2001 Jan 15;193(2):207-18
references.pmid: 11148224
references.citation: Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):E2223-9
references.pmid: 22745171
references.citation: J Exp Med. 2012 Oct 22;209(11):2049-64
references.pmid: 23045607
references.citation: Nat Med. 2011 Jul 24;17(8):975-82
references.pmid: 21785433
references.citation: J Immunol. 2008 Nov 1;181(9):6189-200
references.pmid: 18941209
references.citation: Immunity. 2006 Dec;25(6):977-88
references.pmid: 17174120
references.citation: Nat Rev Immunol. 2012 Nov;12(11):762-73
references.pmid: 23018291
references.citation: Nat Immunol. 2011 Sep 18;12(11):1096-104
references.pmid: 21926986